CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for China Medical Technologies, Inc. (ADR) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

China Medical Technologies, Inc. (ADR)
No. 24 Yong Chang North Road
Beijing Tech. Development Area
Phone: +86 1067871166p:+86 1067871166 BEIJING, BEJ  100176  China Ticker: CMEDQCMEDQ

Filed for Bankruptcy on 8/31/2012
Case #12-13736, filed in the U.S. Bankruptcy Court for the Southern District of New York (Chapter 15)
This company is no longer actively traded on any major stock exchange.

Business Summary
China Medical Technologies, Inc. (China Medical) is principally engaged in the commercialization, manufacture and sale of medical devices and supplies to customers primarily in the People’s Republic of China. The Company develops, manufactures and markets advanced immunodiagnostic and molecular diagnostic products utilizing enhanced chemiluminescence immunoassay (ECLIA) technology, fluorescent in situ hybridization technology (FISH) technology and surface plasmon resonance (SPR) technology. It operates in two segments: immunodiagnostic systems and molecular diagnostic systems. Immunodiagnostic products include ECLIA analyzers and reagent kits, while molecular diagnostic products include FISH probes, SPR analyzers and surface human papillomavirus-deoxyribonucleic acid (HPV-DNA) chips.
(Source: 20-F)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20113/31/2011YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer XiaodongWu 55 2/1/2005 7/1/2004
Chief Financial Officer, Director TakyungTsang 40 6/1/2007 1/1/2005
Senior Vice President - Operations FengZhu 42 10/1/2009 1/1/2005
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Beijing Bio-Ekon Biotechnology Co., Ltd.
Beijing GP Medical Technologies Co., Ltd.
Beijing Yuande Bio-Medical Engineering Co., Ltd.
12 additional Business Names available in full report.

General Information
Number of Employees: 897 (As of 6/30/2011)
Outstanding Shares: 324,080,001 (As of 9/30/2011)
Stock Exchange: OTC
Federal Tax Id: 000000000
Fax Number: +86 1067889588


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023